Literature DB >> 25686383

Willingness to participate in mammography screening: a randomized controlled questionnaire study of responses to two patient information leaflets with different factual content.

Elisabeth Gummersbach, Jürgen in der Schmitten, Achim Mortsiefer, Heinz-Harald Abholz, Karl Wegscheider, Michael Pentzek.   

Abstract

BACKGROUND: From 2010 onward, a new leaflet about mammography screening for breast cancer, more informative than the preceding version, has been sent to women in Germany aged 50 to 69 with the invitation to undergo screening. The purpose of this study was to determine the effect of different informational content on the decision whether or not to be screened.
METHODS: In a randomized and blinded design, 792 women aged 48 to 49 were sent either the old or the new leaflet. Questionnaires were sent together with the leaflets in order to assess the following: willingness to undergo mammography screening, knowledge, decisional confidence, personal experiences of breast cancer, and demographic data.
RESULTS: 370 (46.7%) of the questionnaires were returned, and 353 were evaluable. The two groups did not differ significantly in their willingness to be screened: 81.5% (95% confidence interval [CI] 75.8%-87.2%) versus 88.6% (95% CI 83.9%-91.3%, p = 0.060). A post-hoc analysis showed that women who reported having had personal experience of breast cancer (18.7%) were more willing to be screened if they were given the new leaflet, rather than the old one (interaction p = 0.014). The two groups did not differ in their knowledge about screening (p = 0.260). Women who received the old leaflet reported a higher decisional confidence (p = 0.017). The most commonly mentioned factors affecting the decision were experience of breast cancer in relatives and close acquaintances (26.5% of mentions) and a doctor's recommendation (48.2%). Leaflets (3.6%) and all other factors played only a secondary role.
CONCLUSION: The greater or lesser informativeness of the leaflet affected neither the participants' knowledge of mammography screening nor their willingness to undergo it. The leaflet was not seen as an aid to decision-making. The best way to assure an informed decision about screening may be for the patient to discuss the matter personally with a qualified professional.

Entities:  

Mesh:

Year:  2015        PMID: 25686383      PMCID: PMC4335580          DOI: 10.3238/arztebl.2015.0061

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  22 in total

1.  Mammography screening: are women really giving informed consent? (Countering the counterpoint).

Authors:  Cornelia J Baines
Journal:  J Natl Cancer Inst       Date:  2003-10-15       Impact factor: 13.506

2.  Breast cancer screening; cost-effective in practice?

Authors:  H J De Koning
Journal:  Eur J Radiol       Date:  2000-01       Impact factor: 3.528

3.  Women's knowledge about breast cancer risk and their views of the purpose and implications of breast screening--a questionnaire survey.

Authors:  Premila Webster; Joan Austoker
Journal:  J Public Health (Oxf)       Date:  2006-08-10       Impact factor: 2.341

4.  [Criteria for evidence-based patient information].

Authors:  Anke Steckelberg; Bettina Berger; Sascha Köpke; Christoph Heesen; Ingrid Mühlhauser
Journal:  Z Arztl Fortbild Qualitatssich       Date:  2005

5.  Informed choice in mammography screening: a randomized trial of a decision aid for 70-year-old women.

Authors:  Erin Mathieu; Alexandra Barratt; Heather M Davey; Kevin McGeechan; Kirsten Howard; Nehmat Houssami
Journal:  Arch Intern Med       Date:  2007-10-22

Review 6.  Informed decision making: what is its role in cancer screening?

Authors:  Barbara K Rimer; Peter A Briss; Paula K Zeller; Evelyn C Y Chan; Steven H Woolf
Journal:  Cancer       Date:  2004-09-01       Impact factor: 6.860

7.  Breast cancer screening programmes in 22 countries: current policies, administration and guidelines. International Breast Cancer Screening Network (IBSN) and the European Network of Pilot Projects for Breast Cancer Screening.

Authors:  S Shapiro; E A Coleman; M Broeders; M Codd; H de Koning; J Fracheboud; S Moss; E Paci; S Stachenko; R Ballard-Barbash
Journal:  Int J Epidemiol       Date:  1998-10       Impact factor: 7.196

8.  [Informed consent for patients on early recognition of prostate carcinoma is insufficient].

Authors:  C Börgermann; F vom Dorp; R Rossi; M Schenck; H-J Luboldt; H Rübben
Journal:  Urologe A       Date:  2009-09       Impact factor: 0.639

Review 9.  Decision aids for people facing health treatment or screening decisions.

Authors:  Annette M O'Connor; Carol L Bennett; Dawn Stacey; Michael Barry; Nananda F Col; Karen B Eden; Vikki A Entwistle; Valerie Fiset; Margaret Holmes-Rovner; Sara Khangura; Hilary Llewellyn-Thomas; David Rovner
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

10.  [Information on mammography screening--from deception to insight].

Authors:  I Mühlhauser; B Höldke
Journal:  Radiologe       Date:  2002-04       Impact factor: 0.635

View more
  11 in total

1.  Recommendations on screening for breast cancer in women aged 40-74 years who are not at increased risk for breast cancer.

Authors:  Scott Klarenbach; Nicki Sims-Jones; Gabriela Lewin; Harminder Singh; Guylène Thériault; Marcello Tonelli; Marion Doull; Susan Courage; Alejandra Jaramillo Garcia; Brett D Thombs
Journal:  CMAJ       Date:  2018-12-10       Impact factor: 8.262

2.  First Prospective Cross-Sectional Study on the Impact of Immigration Background and Education in Early Detection of Breast Cancer.

Authors:  Elna Kuehnle; Wulf Siggelkow; Kristina Luebbe; Iris Schrader; Karl-Heinz Noeding; Stefanie Noeding; Thomas Noesselt; Peter Hillemanns; Thilo Dörk; Tjoung-Won Park-Simon
Journal:  Breast Care (Basel)       Date:  2020-11-24       Impact factor: 2.268

3.  Subjective and Objective Cancer Screening Knowledge Among White- and Blue-Collar Chinese Midlife Adults.

Authors:  Su-I Hou
Journal:  J Cancer Educ       Date:  2018-02       Impact factor: 2.037

4.  [Cervical cancer in Mecklenburg-Western Pomerania. Tumor stage, histological tumor type, age and screening participation of 985 patients].

Authors:  K Marquardt; M Stubbe; U Broschewitz
Journal:  Pathologe       Date:  2016-02       Impact factor: 1.011

5.  Scarce information about breast cancer screening: An Italian websites analysis.

Authors:  Francesco Attena; Mariagrazia Cancellieri; Concetta Paola Pelullo
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

Review 6.  Health Literacy Interventions in Cancer: a Systematic Review.

Authors:  A J Housten; C M Gunn; M K Paasche-Orlow; K M Basen-Engquist
Journal:  J Cancer Educ       Date:  2020-11-05       Impact factor: 2.037

7.  Effect of an information leaflet on breast cancer screening participation: A cluster randomized controlled trial.

Authors:  Jose Maria Montero-Moraga; Margarita Posso; Marta Román; Andrea Burón; Maria Sala; Xavier Castells; Francesc Macià
Journal:  BMC Public Health       Date:  2021-07-03       Impact factor: 3.295

8.  Informed Choice in the German Mammography Screening Program by Education and Migrant Status: Survey among First-Time Invitees.

Authors:  Eva-Maria Berens; Maren Reder; Oliver Razum; Petra Kolip; Jacob Spallek
Journal:  PLoS One       Date:  2015-11-03       Impact factor: 3.240

9.  The effect of information about the benefits and harms of mammography on women's decision-making: study protocol for a randomized controlled trial.

Authors:  Misericòrdia Carles; Montserrat Martínez-Alonso; Anna Pons; Maria José Pérez-Lacasta; Lilisbeth Perestelo-Pérez; Maria Sala; Carmen Vidal; Montse Garcia; Ana Toledo-Chávarri; Núria Codern; Maria Feijoo-Cid; Anabel Romero; Roger Pla; Jorge Soler-González; Xavier Castells; Montserrat Rué
Journal:  Trials       Date:  2017-09-12       Impact factor: 2.279

Review 10.  Assessment of the effects of decision aids about breast cancer screening: a systematic review and meta-analysis.

Authors:  Montserrat Martínez-Alonso; Misericòrdia Carles-Lavila; Maria José Pérez-Lacasta; Anna Pons-Rodríguez; Montse Garcia; Montserrat Rué
Journal:  BMJ Open       Date:  2017-10-06       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.